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STATUS OF BROMETHALIN OUTSIDE THE UNITED ST ATES 
S.R. SPAULDING, Ciba-Geigy Animal Health/Hygiene, CH-4002 Basel, Switzerland. 
H. SPANNRING, Ciba-Geigy Agriculwral Research Centre, St. Aubin, Switzerland. 
ABSTRACT: Bromethalin has been extensively researched over the past decade in the United States, Switzerland, England, 
Denmark, and France. United States EPA registrations were received in 1982 and commercial pelleted formulations 
containing 0.01 % bromethalin were developed and introduced in the USA by Ralston Purina (ASSA UL TR) in 1985 and 
Velsicol (VENGEANCER) in 1986. Ciba-Geigy is currently developing new formulations under the tradename DORA TIDR 
for use outside the United States. Bromethalin acute toxicity and 14-day subchronic studies are reviewed and data from 
recently completed 90-day subchronic studies required for registration outside the US are presented. Pharmacodynamic 
studies have shown that bromethalin acts as an uncoupler of oxidative phosphorylation, thus interrupting the vital production 
of ATP necessary to maintain essential metabolic functions. Laboratory and field trial data are presented from Switzerland, 
France, England, and Denmark that indicate the effectiveness of new bromethalin formulations againstanticoagulantrcsistant 
and susceptible rodents. A comparative rodenticide pen testing system is described from which test results confirm 
bromethalin's quick action and feed consumption efficiency when compared to second-generation anticoagulants. 
INTRODUCTION 
The worldwide development ofbromethalin has been an 
expensive and lengthy process lasting over a decade. It has 
involved the dedicated work of people from a variety of 
disciplines including chemists, biologists, toxicologists, 
formulation scientists, regulatory specialists, and marketers. 
The search for a novel rodenticide with a mode of action 
different from anticoagulants began in the mid-1970's when 
leads from a fungicide screening program at Lilly Research 
Laboratories indicated the rodenticidal potential of a group of 
compounds classified as diphenylamines (Dreikom and 
O'Doherty 1984). After several years of screening and struc-
ture-activity relation tests, bromethalin was identified as the 
compound with the greatest biological potential. At the 1979 
British Crop Protection Conference, Dreikom (1979) pre-
sented the first biological results from laboratory tests with 
white rats and mice. Biological and toxicological testing 
continued at Lilly until sufficient data were assembled to 
submit an application for an Experimental Use Permit (EUP). 
In 1980, the EUP was issued by the Environmental Protection 
Agency (EPA) and a field trial program was initiated in 
conjunction with the Center for Environmental Research at 
Bowling Green State University. By the end of 1981, 17 
successful field trials in Norway rat and house mouse infested 
sites were completed and the EPA granted bromethalin 
registration for use in and around buildings in 1982. 
Marketing rights were subsequently licensed by Eli Lilly 
to Ralston Purina and Velsicol in the United States and Ciba-
Geigy for all countries outside the United States. Ciba-Geigy 
initiated development in 1984 under the tradename DORAT-
IoR. During the following year, ASSA UL TR was introduced 
into U.S. markets by Ralston Purina, and Velsicol followed 
Proc. Vertebr. Pest C.Onf. (A.C. Crabb and R.E. Marsh, Eds.), 
Printed at Univ. of Calif., Davis. 13:64-69, 1988 
in 1986 with the introduction of Vengeance. Over the past 4 
years, Ciba-Geigy has focused on formulation development 
of grain-based baits and a bonded weather-resistant block, as 
well as conducting several additional toxicology swdies 
required to meet European registration requirements. This 
work is now coming to an end and registration was initiated 
in 1988 in selected European countries. 
It is the intent of this paper to review the status of 
bromethalin and to discuss efficacy and toxicology studies 
conducted outside the United States over the past 4 years. 
REVIEW OF SELECTED BROMETHALIN TOXICO-
LOGICAL PROPERTIES 
Toxicological aspects of bromethalin have been previ-
ously reviewed by Jackson et al. (1982), Spaulding et al. 
(1985), and Spaulding (1987). This brief review of toxico-
logical data focuses on acute and subchronic toxicity and 
aspects related to pharmacodynamics, pharmacokinetics, 
and metabolism. 
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Acute Toxicity 
Bromethalin acute LD 50 values for the active ingredient 
in target and non-target species range from 1.8 mg/kg (cat) to 
13.0 mg/kg (rabbit). LD50's of 2.3, 6.7, and 6.6 mg/kg have 
been determined for the Norway rat, house mouse, and roof 
rat, respectively. The acute LD50 of the 0.01 % finished bait 
is >2000 mg/kg. 
Subchronic Toxicity 
S ubchronic and chronic toxicity tests with pesticides are 
designed to assess the toxicity and human carcinogenicity 
risk to humans in prolonged exposure situations. The EPA 
required only 14-day feeding studies with bromethalin to 
suppon registration in the United States; however, 90-day 
feeding studies were required for registration in several 
European countries. While these 90-day tests are cenainly 
applicable in the case of herbicides and insecticides applied 
to crops, the scientific value of these studies withrodenticides 
is questionable due to completely different use pauerns. 
Rodenticides are applied in discrete locations in relatively 
small quantities; therefore, the potential for human exposure 
or food contamination is minimal. 
In several early toxicity studies with bromethalin (van 
Lier et al. 1980, van Lier and Ottosen 1981), histopathologi-
cal signs of toxicity indicated vacuolation of the white matter 
of the brain and spinal cord, which appeared as a spongy 
degeneration. To detennine whether this spongy degenera-
tion was a reversible phenomenon, two 14-day subchronic 
reversibility studies were undenaken (van Lier et al. 1980, 
van Lier and Cherry 1988). Rats were dosed with 0, 0.5, 2 or 
8 ppm bromelhalin in one study and 0, I, 3, and 5 ppm 
bromelhalin in a second study. Brain, spinal cord and sciatic 
nerve tissues were examined histologically over an 8-week 
recovery period. Behavior and motor coordination were 
measured in the second study using a rotorod. All rats given 
8 ppm bromethalin died during treatment or were killed when 
moribund. Leg weakness and depressed motor function were 
observed by day 7 in rats given 5 ppm bromethalin. Electron 
and light microscopic examination of rat tissues taken at 
various times during these studies demonstrated that the 
primary lesions which occurred were spongy degeneration of 
the CNS white matter. However, the incidence of spongy 
degeneration decreased sharply at two and four weeks post· 
treatment and was not evident at eight weeks posttreatment, 
demonstrating the reversibility of these lesions. Furthennore, 
histological examination of tissues revealed no evidence of 
cell necrosis. 
In order to conduct 90-day subchronic toxicity studies 
with inherently toxic rodenticides, extremely low doses must 
be administered in order to keep test animals alive throughout 
the 90-day test period. These doses were established for 
bromethalin subchronic studies by conducting 4-week pilot 
studies first with rats and dogs. In definitive studies (Ciba-
Geigy, unpubl. repL), rats and dogs were dosed with 0, 5, 25, 
125, and 200 (dogs only) mcg/kg bromethalin daily over 90 
days. Lesions were evident only atdosesof;?.125 mcg/kgand 
were characterized by the typical spongy degeneration of 
CNS white mau.er seen in the 14-day studies. Even under 
extended subchronicexposure, a "no observable effect level" 
(NOEL) of 25 mcg/kg was demonstrated in rats and dogs. 
Pbannacodynamics/Phannacokinetics/Metabo!ism 
Several studies have been conducted to investigate the 
mechanism of action, metabolism, tissue distribution and 
excretion of bromethalin in laboratory rats. Van Lier and 
Cherry (l 988) recently described the mechanism of action of 
bromelhalin. Based upon theirresults from several mechanis· 
tic studies, the following mode of bromethalin toxicity is 
proposed. Upon ingestion, bromethalin is metabolized to 
desmethyl bromethalin which uncouples oxidative 
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phosphorylation in themiiochondria. The sodium/potassium 
gradient nonnally maintained by sodium-potassium A TPase 
is weakened, and fluid builds up in the cell. While most 
tissues and organs can expand slightly to accommodate this 
effect, a fluid build-up inside the central nervous system leads 
to increased pressure on nerve axons. Dcmyelination occurs 
and nerve impulse transmission is reduced. In the lethally 
intoxicated animal, this leads to inadequate transmission to 
respiratory centers with ultimate respiratory arrest and death. 
The entire process is dose-dependent and death generally 
occurs from 12-72 hours following ingestion. 
Studies with radio-labelled bromethalin have provided 
insights into the pharmacokinetic and metabolic aspects of 
bromethalin (van Lier and Ottosen 1981, van Lier and Cherry 
1988). One study using radio-labelled bromelhalin resulted 
in disappearance of radiocarbon from plasma at a rate which 
indicated a half-life of about 135 hours. Other studies using 
radio-labelled bromethalin indicated excretion is primarily 
through the feces and that bromethalin is absorbed after oral 
administration and distributed primarily to the fat, liver, 
gastrointestinal tract, adrenals, ovaries and thyroid tissues. 
LABORATORY EFFICACY STUDIES 
Laboratory choice tests were conducted with a variety of 
0.01% bromethalin grain-based and weather-resistant 
bonded block formulations using anticoagulant susceptible 
and resistant Bllllil£ norvegicus and Ml1£ musculus. The 
studies were conducted at the following international re-
search institutes: 
I. Ciba-Geigy Agricultural Research Centre· Switzerland 
2. !NRA, Laboratoire de la Faune Sauvage · France 
3. Danish Pest Infestation Laboratory • Denmark 
4. MAFFTollworth Laboratories· U.K. Ministry of Agricul-
ture, Fisheries and Food 
Data from the Ciba-Geigy Agricultural Research Centre 
have been published in part by Spaulding (1987). 
A pooled data summary of choice tests with hromethalin 
grain-based fonnulations using individually-caged wild R. 
norvegjcus is presented in Table I. A total of 422 rats were 
used in 27 different tests. Formulations included 0.01% 
bromethalin whole oats and wheat, cracked or pinhead oats, 
or oat flakes. Average percent monality of 97% (range 94-
100%) was achieved within an average of 2.3 days (range 1.4· 
4.0days) following ingestionofbromethalin baits. Fonnula· 
lions containing bromethalin were consumed an average of 
48% (range 30-71 %) of the time compared to untreated 
alternative diets. 
A pooled data summary of choice tests with bromethalin 
weather-resistant block formulations using individually· 
caged R. norvei:icusispresented in Table 2. A total of 14 5 rats 
were used in 11 different tests. Formulations consisted of 
whole wheat or oats or cracked maize impregnated with 
0.01 % bromelhalin and bonded together in a patented proc-
ess. Laboratory tests have shown this fonnulation to be highly 
palatable to rats and resistant to moisture and heat Average 
percent monality of 96% (range 83-100%} was achieved 
within an average of 3.5 days (2.l-4.6 days) following 
Table l: Choice tests with 0.01 % Bromethalin Grain Fonnu-
lations Against Individually-Caged &. norvegicus. 
N Bromethalin Mort- Days lo 
Country* Grain (No.Tests) Consumption ality Death 
% % 
SWIT1 Oats 22(2) 47 95 2.9 
SWIT1 Oats 100(7) 63 98 2.1 
SWIT1 Oats 32(2) 33 94 1.9 
SWIT1 Cracked 100(5) 71 99 1.7 
Oats 
SWIT1 Cracked . 48(3) 57 96 l.4 
Oats 
SWIT1 Wheat 40(2) 30 100 2.4 
FRANCE2 Oats/ 40(2) 30 98 1.8 
Wheat 
DENMK3 Oat 20(2) 43 100 4.0 
Flakes/Wheal 
GRBRIT4 Wheal/ 20(2) 56 90 2.7 
Oats (pinhead) 
N=422 x =48 x = 97 
"Source: 1. Ciba-Geigy Unpublished Repon 
2. Grolleau. 1987. Proceedings Rome EPPO/FAO 
Conference on Rodent.s 
3. Lund. 1986. Unpublished Data 
4. Greaves. 1986. Unpublished Data 
x =2.3 
ingestion of the bromethalin blocks. Blocks containing brom-
ethalin were consumed an average of 60% (range 47-82%) of 
the time compared to untreated alternative blocks. 
A pooled data summary of choice tests with bromethalin 
grain-based formulations using family groups (8-20 mice/ 
group) of wild M. musculus is presented in Table 3. Formu-
lations included 0.01 % bromethalin canary seed, cracked 
oats, or oat flakes. A total of 326 mice were used in 20 
different tests. Average percent mortality of 97% (range 92-
100%) was achieved within an average of 2.3 days (range 1.5-
2.8 days) following ingestion ofbromethalin baits. Formula-
tions containing bromethalin were consumed an average of 
59% (range 37-88%) of the time compared to untreated 
alternative diets. 
A pooled data summary of laboratory tests with brom-
ethalin grain-based formulations using anticoagulanl-
resistant.R.. norvegicus and M. musculus is presented in Table 
4. A total of 170 resistant rodents were tested at research 
institutes in France, England, and the United States. The R.. 
Table 2. Choice Tests with 0.01% Bromelhalin Weather-
Resislant Block Formulations Against Individually-Caged 
.R. norvegicus. 
N Bromethalin Mort- Days to 
Country* Grain (No.Tests) Consumption ality Death 
% % 
SWIT1 Wheal 24(2) 72 100 2.1 
SWIT1 Wheat 12(1) 67 100 4.1 
swrr• Maize 24(2) 47 100 4.0 
SWIT Oats 15(1) 82 100 3.4 
FRANCE2 Wheat/ 40(2) 47 95 2.8 
Oats 
DENMK3 Wheat/ 30(3) 47 83 4.6 
Oats 
N = 145 x=60 x=96 x=3.5 
"Source: 1. Ciba-Geigy Unpublished Repon 
2. Grolleau. 1987. Proceedings RomeEPPO/FAO 
Conference on Rodent.s 
3. Lund. 1986. Unpublished Data 
4. Greaves. 1986. Unpublished Data 
Table 3. Choice Tests with0.01 % Bromethalin Grain Fonnu-
lations Against Family Groups of M. musculus 
N Bromethalin Mort- Days lo 
Country* Grain (No.Tests) Consumption ality Death 
% % 
SWIT1 Canary 30(3) 66 98 2.8 
Seed 
SWIT1 Oat Flakes 10(1) 88 100 1.5 
SWIT1 Cracked 106(8) 37 97 2.1 
Oats 
FRA2 Canary 60(3) 54 92 2.3 
Seed/Oat Flakes 
DENMK3 Canary 120(5) 48 100 2.6 
Seed/Oat Flakes 
N=326 x =59 x=97 x = 2.3 
'Source: 1. Ciba-Geigy Unpublished Report 
2. Grollcau. 1987. Proceedings Rome EPPO/FA Conference 
onRodcnu 
3. Lund. 1986. Unpublished Data 
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Table 4. Laboratory Tesis with O.oJ % Bromethalin Grain 
Formulations Using Anticoagulant-Resistant&. norvegicus 
(RN) and M. m~ul~ (MM). 
N Bromethalin Mort-
Country••• Species (# ToslS) Consumption ality 
% % 
FRA' RN* 10 No-Choice 100 
FRA' RN* 20 30 80 
GB1 RN 10 63 100 
GB1 MM 30 51 87 
USA' RN 50 33** 95 
USA' MM 50 48** 90 
N=l70 x=45 x=92 
•Bromadiolone~rcristant 
•• 0.005% bromethalin in EPA diet 
•••Source: J. GroUean. 1987. Proceedings Rome BPPO/ PAO 
Conference on Rodents 
2. Greaves. 1986. Unpublished data 
3. Iacb-On a al. 1982. Proc. 10th Vert. Pest Conf. 
Days to 
Death 
1.6 
3.4 
1.7 
2.4 
4.0 
4.0 
x =2.9 
norve11icus tested in France were determined resistant to 
bromadiolone.Averagepercentmonalityof92% (range80-
100%) was achieved within an average of 2.9 days ( I.6-4.0 
days) following ingestion ofbromethalin bailS. Fonnulations 
con1aining bromethalin were consumed an average of 45% 
(range30-63%) of the time compared to untreated alternative 
diets. 
FIELD EFFICACY TRIALS 
Seventeen (17) field trials were completed with 0.005% 
bromethalin EPA bailS in primarily rural sites such as live-
stock barns, poultry farms and storage buildings in 5 geo-
graphically different regions of the United States (Jackson et 
al. 1982, Spaulding et al_ 1985). Average percent reduction 
in rodent activity in these trials ranged from 90-98% in 8 &. 
noryegjcus tests and from 85-99% in 9 M- muscUll!S tests. 
Bromethalin treatment periods ranged from 7-30 days and 
there were no incidents of primary or secondary poisoning to 
non-iarget species during lhe trial program. 
Field trials completed ouiside lhe United States are 
summarized in Tables Sand 6 for R. norvegjcus and M. 
muscu!us. respectively. Nine (9) &. norvegicps infestations 
were treated wilh 0.005% or 0.01 % bromelhalin grain bailS 
in Switzerland, Denmark, England, Ireland and Brazil. 
Average percent reduction in census feed consumption 
ranged from 83 to 100% after 3 IO 14 days of exposure to 
bromelhalin bailS. Four (4) M. musculus populations were 
treated wilh 0.01 % bromethalin grain bailS in France and 
Switzerland. Average percent reduction in census feed con-
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sump ti on ranged from 98 to 100% with 3 to 16 days of 
exposure to bromethalio baits. One hundred-fifty (150) 
mouse carcasses were recovered during the trial in France. 
There were no incidents of primary or secondary poisoning 
to non-target species in these trials. 
Table 5. Field Trials with 0.005% and 0,01 % Bromethalin 
Grain Formulations Against Infestations of&. norvegicus. 
Trealment 
Country Site Days 
SWIT Indoor 6 
Pen 
DK Swine 4 
Barns 
GB** Farm Bldg. 14 
IRL Railway 3 
Station 
BRA** Urban 4 
Slum 
•Pooled Summal)' of 3 Trials 
••0,005% Bromelha1in BaitS 
Reduction 
rodent activity 
% 
100 
83(75-93)* 
90(80-100)* 
100 
100 
Reference 
Ciba-Geigy 
Rept. 11-44 
Lund Unpubl 
Data 1986 
Meehan 1983 
Proc. 61h 
BPCA Conf. 
Ciba-Geigy 
Rept. II-47 
Carvalho 1985 
Biologico 
Table 6. Field Trials with 0.0 l % Bromelhalin Grain Formu-
lations Against Infestations of M. musculus. 
Trealment Reduction 
Country Site Days rodent activity Reference 
FRA Farm Bldg. 3 98 
SW!T Indoor Pen 7 100 
SWIT Swine Barn 3 
SWIT Warehouse 16 
RODENTICIDE PEN TESTING 
Test Procedure 
98 
99 
Grolleau 
Unpubl Data.1987 
Ciba-Geigy Rept. 
11-42 
Ciba-Geigy Rept. 
II -43 
Ciba-Geigy Rept. 
Il-48 
An indoor pen testsystem was established so !hat indirect 
comparisons of rodenticides could be made under similar 
conditions. Indoor pens measuring 4x2x2 (8 m2) were con-
structed on a concrete base with slain less steel wire mesh. The 
bottom of the pens was covered with approximately 10 cm of 
saw dust and abundant harborage was provided in the form of 
ovenumed plastic containers. Wild male and female Norway 
rats were introduced into the pen and provided standard 
laboratory diet and water &1 libitum. Rodents were allowed 
lo acclimate for I 0-12 weeks before testing and obviously 
dominant or submissive animals were removed. Twelve ( 12) 
bait trays conlaining either 2 kg of rodenticide or untreated 
grain were distributed throughout the pen. The position of the 
bail trays was alternated daily and consumption was meas-
ured. Dead animals were removed when located. A diagram 
of the testing facility is shown in Figure I. 
Fig. 3. Efficacy of 0.005'10 Bromadiolone oat baits in a pen trial with 92 
0000 
<)D<)D I wild Norway rats. ·~1 
ro-:oi 
u 
<) D·<) D 
D D 
c 0 0 0 0 
4 m 
0 • Rodentic:1de 
0 • Untreated Grain 
Fig. l. Diagram of rodenticide test pens. 
Comparative Rodenticide Tests 
A a Harbora9P, Box~s 
8 ~ r .. eding A rt>a 
C 11 Water · 
l 
The objective of these tests was to compare the palata-
bility and efficacy of bromethalin with leading second-
generation anticoagulants under controlled conditions. 
Results from tests with 0.01 % bromethalin and 0.005% 
bromadiolone oat formulations and 0.005% brodifacoum 
commercial pelleted formulations are presented in Figures 2, 
3, and 4, respectively. 
1000 
-·-·-·-.-· 
100 .. 
-· /. 
n liOO 1· SO'.l 5 ;;. E. 
·•· P..fort~IHy ~ . 600 X~ W't < ~ -o- Untr~tN Cr<11n i • • 0.01'41 Bromcth~Hn x ~ 40 .. 0 . 400 ;: . 0 ~ u ~ " 200 !Oli < "-':~ " 
0 
• ....,.....__.__•-+----+--•-+-• D'l 
5 7 8 9 10 
Fig. 2. Efficacy of 0.01 'ID Bromethalin oat baits in a pen trial wilh 125 
Norway rats. 
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10 
Day• 
Fig. 4. Efficacy of 0.005% Brodifacoum pellets in a pen trial with 94 
Norway Tiil$. 
" 
A total of 836 g of untreated oats and 973 g of 0.01 % 
bromethalin oat baits were consumed by 125 &. norvegicus 
in the bromethalin test pen over 6 days. This corresponds to 
28.7 g ofbromethalin bait/kg rat and 24.7 g untreated grain/ 
kg rat. Complete mortality was achieved by the sixth day of 
baiting {X= 2.4 days). 
In the bromadiolone test pen, a total of 1722 g of 
untreated oats and 1628 g of0.005% bromadiolone oat baits 
were consumed by 92 &. norvegicus over 10 days. This 
corresponds to 99 .1 g of bromadiolone bail/kg rat and 93. 7 g 
untreated grain/kg rat. Complete mortality was achieved by 
the 10th day of baiting (X' = 5.5 days). 
A total of6615 gofuntreatedgrainand I442gof0.005% 
brodifacoum pellets were consumed by 94 &. norvegicus 
over the 10-day test period. This corresponds to 60. l g of 
brodifacoum bait/kg rat and 2 75.6 g of untreated grain/kg rat. 
Incomplete mortality of 83% (78/94) was achieved after 10 
days of baiting. Rats which survived after 6 days fed almost 
exclusively on untreated grains rather than brodifacoum 
pellets. 
Results from lhese tests illusuate differences between 
the two second-generation anticoagulants and bromethalin 
based upon their respective modes or action and fonnulation 
types. Rais continued LO feed on the two anticoagulants over 
the 10 day test period resulting in at least 2 LO 3 times more 
anticoagulant bait consumption and 3 lO 11 times more 
umreated grain consumption when compared to results from 
the bromethalin test pen. Feed consumption in the brom-
ethalin pen virtually stopped after 4 days, indicative of !he 
eff'lciency of bromethalin baiting under semi-natural condi-
tions. Dead rodents were rapidly observed within 24 hours 
after baiting with bromethalin and complete mortality was 
achieved by the 6th day as compared to 10 days with 
bromadiolone. Untreated grain was preferred over pelleted 
brodifacoum fonnulations leading to incomplete mortalily 
with this product under these experimental conditions. 
Overall, these results illustrate the quick kill and effi-
ciency possible when utilizing bromethalin as an alternative 
to anticoagulant rodenticides for controlling Norway rat 
infestations. 
CONCLUSIONS 
The diphenylamine rodenticide bromethalin has been 
thoroughly researched over !he past decade and commercial 
formulations have been safely used in and around buildings 
in the United States over the past 3 years. International 
development work has shown bromethalin IO be effective 
against susceptible and anticoagulant-resistant rodents. Data 
required for European registrations are nearly complete and 
will besubmiued LO authorities in selected countries through-
out 1988. Bromethalin • squick kill and stop-feed action make 
this rodenticide a highly efficient alternative to anticoagu-
lants. 
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